The importance of implementing safe sharps practices in the laboratory setting in Europe

Biochemia Medica

Volumn 24, Issue 1, 2014, Pages 45-56

  De Carli, Gabriella ^a   Abiteboul, Dominique ^b   Puro, Vincenzo ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Accident prevention; Bloodborne pathogens; Laboratories; Needlestick injuries; Occupational exposure

Indexed keywords

BLOOD SAMPLING; BLOODBORNE BACTERIUM; CLINICAL PRACTICE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EMOTIONAL STRESS; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LABORATORY; MEDICAL DEVICE; MEDICAL EDUCATION; MEDICAL PROCEDURES; NEEDLESTICK INJURY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PHLEBOTOMY; REVIEW; RISK ASSESSMENT; VACCINATION;

ACCIDENT PREVENTION; BLOODBORNE PATHOGENS; LABORATORIES; NEEDLESTICK INJURIES; OCCUPATIONAL EXPOSURE;

COMMUNICABLE DISEASES; EUROPE; HEALTH PERSONNEL; HUMANS; LABORATORIES; NEEDLESTICK INJURIES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS;

EID: 84893608883     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/BM.2014.007     Document Type: Review

References (57)

1. Council of the European Union. Council Directive 2010/32/ EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU. Official Journal of the European Union. 2010 (June 1):L 134(53):66-72. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:134:0066:0072:EN:PDF. Accessed September 23, 2013.
2. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-90. http://dx.doi.org/10.1056/NEJM199711203372101.
3. Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005;41:1423-30. http://dx.doi.org/10.1086/497131.
4. Puro V, De Carli G, Segata A, Piccini G, Argentero PA, Signorini L, et al.Update on the subject of epidemiology of blood-transmitted occupational infections. G Ital Med Lav Ergon 2010;32:235-9.
5. Ippolito G, Puro V, Petrosillo N, De Carli G, Micheloni G, Magliano E. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure. JAMA 1998;280:28. http://dx.doi.org/10.1001/jama.280.1.28.
6. Lot F, Abiteboul D. Surveillance des contaminations professionnelles par le VIH, le VHC et le VHB chez le personnel de santé. Situation au 31 décembre 2009. Rapport. Saint-Maurice: Institut de veille sanitaire; 2010. 8 p. Available at: http://opac.invs.sante.fr/doc_num.php?explnum_id=63. Accessed September 23, 2013 (in French).
7. Health Protection Agency Centre for Infections. Occupational transmission of HIV. Summary of published reports. March 2005 Edition. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947320156. Accessed September 23, 2013.
8. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M, Kovalevskaya S, et al. Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA). Clin Chem Lab Med 2013;51:1585-93.
9. Lamontagne F, Abiteboul D, Lolom I, Pellissier G, Tarantola A, Descamps JM, et al. Role of safety-engineered devices in preventing needlestick injuries in 32 French hospitals. Infect Control Hosp Epidemiol 2007;28:18-23. http://dx.doi.org/10.1086/510814.
10. Migueres B, Pellissier G, Goyer F, Touche S, Alcouffe J, Fabin C, et al. Risque d'exposition au sang lors des prélèvements veineux. Résultats d'une étude dans les laboratoires d'analyses médicales. Doc Med Trav 2007;110:173-92.
11. Council of the European Union. Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work. Official Journal L 183, 29/06/1989 p. 0001-8. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31989L0391:EN:HTML. Accessed September 23, 2013.
12. Council of the European Union. Council Directive 2000/54/EC of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work. Official Journal of the European Communities. 2000 (Oct 17):L 262(43):21-45. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32000L0054:EN:HTML. Accessed September 23, 2013.
13. From needlesticks to sharps: the added value. Documentary. Reference: I-072260, 13/02/2012. Available at: http://ec.europa.eu/avservices/video/player.cfm?sitelang=en&ref=I072260. Accessed September 23, 2013.
14. Collins CH. Laboratory-acquired infections. 3rd ed. Oxford: Butterworth-Heinemann Ltd.,1993.
15. Leibowitz S, Greenwald L, Cohen I, Litwins J. Serum hepatitis in a blood bank worker. JAMA 1949;140:1331-3. http://dx.doi.org/10.1001/jama.1949.82900520001006.
16. Kuh C, Ward WE. Occupational virus hepatitis: an apparent hazard for medical personnel. JAMA 1950;143:631-5. http://dx.doi.org/10.1001/jama.1950.02910420019006.
17. Trumbull ML, Greiner DJ. Homologous serum jaundice: an occupational hazard to medical personnel. JAMA 1951;145:965-7. http://dx.doi.org/10.1001/jama.1951. 02920310021005.
18. Singh K. Laboratory-acquired infections. Cl Infect Dis 2009;49:142-7. http://dx.doi.org/10.1086/599104.
19. Jagger J, De Carli G, Perry J, Puro V, Ippolito G. Epidemiology and prevention of occupational transmission of bloodborne pathogens through percutaneous injuries. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections, 4th edition. New York: Lippincott Williams & Wilkins; 2003.p.430-66.
20. Petrosillo N, Puro V, De Carli G, Ippolito G; SIROH Group. Studio Italiano Rischio Occupazionale da HIV. Risks faced by laboratory workers in the AIDS era. J Biol Regul Homeost Agents 2001;15:243-8.
21. Tarantola A, Abiteboul D, Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control 2006;34:367-75. http://dx.doi.org/10.1016/j.ajic.2004.11.011.
22. Pedrosa PB, Cardoso TA. Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects. Int J Infect Dis 2011;15:e366-76. http://dx.doi.org/10.1016/j.ijid.2011.03.005.
23. Parszuto J, Jaremin B, Bardoń A, Obuchowska A. Occupational HBV and HCV infections among health care workers. Med Pr 2012;63:441-52.
24. Martins A, Coelho AC, Vieira M, Matos M, Pinto ML. Age and years in practice as factors associated with needlestick and sharps injuries among health care workers in a Portuguese hospital. Accid Anal Prev 2012;47:11-5. http://dx.doi.org/10.1016/j.aap.2012.01.011.
25. Puro V, Ippolito G. Safety butterfly needles for blood drawing. Infect Control Hosp Epidemiol 1998;19:299. http://dx.doi.org/10.1086/647814.
26. Zimmerman JE, Seneff MG, Sun X, Wagner DP, Knaus WA. Evaluating laboratory usage in the intensive care unit: Patient and institutional characteristics that influence frequency of blood sampling. Crit Care Med 1997;25:737-48. http://dx.doi.org/10.1097/00003246-199705000-00006.
27. Speicher CE. The right test: a physician's guide to laboratory medicine. Philadelphia, Pa, WB Saunders Co, 1998.
28. ISO 15189:2012 Standard. Medical laboratories-Requirements for quality and competence, ISO, Geneva.
29. LLopis MA, Alvarez V, Martínez-Brú C, Gómez R, Barba N, Ibarz M, et al. Quality Assurance in the Preanalytical Phase, Applications and Experiences of Quality Control. Prof. Ognyan Ivanov (Ed.), 2011. Available at: http://www.intechopen.com/books/applications-and-experiences-of-qualitycontrol/quality-assurance-in-the-preanalytical-phase. Accessed December 20, 2013.
30. De Carli G, Puro V, Jagger J. Needlestick-prevention devices: we should already be there. J Hosp Infect 2009;71:183-4. http://dx.doi.org/10.1016/j.jhin.2008.10.017.
31. Tosini W, Ciotti C, Goyer F, Lolom I, L'Hériteau F, Abiteboul D, et al. Needlestick injury rates according to different types of safety-engineered devices: results of a French multicenter study. Infect Control Hosp Epidemiol 2010;31:402-7. http://dx.doi.org/10.1086/651301.
32. Hoffmann C, Buchholz L, Schnitzler P. Reduction of needlestick injuries in healthcare personnel at a university hospital using safety devices. J Occup Med Toxicol 2013;8:20. http://dx.doi.org/10.1186/1745-6673-8-20.
33. Adams D, Elliott TS. Impact of safety needle devices on occupationally acquired needlestick injuries: a four-year prospective study. J Hosp Infect 2006;64:50-5. http://dx.doi.org/10.1016/j.jhin.2006.04.012.
34. Valls V, Lozano MS, Yánez R, Martínez MJ, Pascual F, Lloret J, et al. Use of safety devices and the prevention of percutaneous injuries among healthcare workers. Infect Control Hosp Epidemiol 2007;28:1352-60. http://dx.doi. org/10.1086/523275.
35. Beekmann SE, Vaughn TE, McCoy KD, Ferguson KJ, Torner JC, Woolson RF, et al. Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol 2001;22:73-82. http://dx.doi.org/10.1086/501867.
36. Becker MH, Janz NK, Band J, Bartley J, Snyder MB, Gaynes RP. Noncompliance with Universal Precautions policy: why do physicians and nurses recap needles? Am J Infect Control 1990;18:232-9. http://dx.doi.org/10.1016/0196-6553-(90)90164-N.
37. Reddy SG, Emery RJ. Assessing the effect of long-term availability of engineering controls on needlestick injuries among health care workers: a 3-year preimplementation and postimplementation comparison. Am J Infect Control 2001;29:425-7. http://dx.doi.org/10.1067/mic.2001.118404.
38. Beswick A, Robinson E, Evans G, Codling A. An evaluation of the efficacy of safer sharps devices. Systematic review. Health and Safety Executive RR914 2012. Available at: www.hse.gov.uk/research/rrpdf/rr914.pdf. Accessed September 23, 2013.
39. Valim MD, Marziale MH, Richart-Martínez M, Sanjuan-Qui-les A. Instruments for evaluating compliance with infection control practices and factors that affect it: an integrative review. J Clin Nurs 2013; in press. http://dx.doi.org/10.1111/jocn.12316.
40. Parent-Thirion A, Macías EF, Hurley J, Vermeylen G. Fourth European Working Conditions Survey. Available at: http://www.eurofound.europa.eu/. Accessed December 20, 2013.
41. Miller JM, Astles R, Baszler T, Chapin K, Carey R, Garcia L, et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. MMWR Surveill Summ 2012;61 Suppl:1-102.
42. Main CL, Carusone SC, Davis K, Loeb M. Compliance with personal precautions against exposure to bloodborne pathogens among laboratory workers: a Canadian survey. Infect Control Hosp Epidemiol 2008;29:66-8. http://dx.doi.org/10.1086/524325.
43. Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 1982;115:26-39.
44. Snydman DR, Munoz A, Werner BG, Polk BF, Craven DE, Platt L, et al. A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol 1984;120:684-93.
45. Topuridze M, Butsashvili M, Kamkamidze G, Kajaia M, Morse D, McNutt LA. Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: An international perspective. Infect Control Hosp Epidemiol 2010;31:158-64. http://dx.doi.org/10.1086/649795.
46. De Carli G. Reporting of occupational exposures. Presented at the 3rd European Biosafety Summit, London, 1 June 2012. Available at: http://www.europeanbiosafetynetwork.eu/london-summit-2012. Accessed September 23, 2013.
47. Breslin A, Breslin T, Clarke S, Crowley B, Feeney T, Fitzgerald D, et al. Guidelines for the Emergency Management of Injuries. Available at: https://www.hpsc.ie/hpsc/A-Z/Hepatitis/EMIToolkit/f. Accessed December 20, 2013.
48. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers: Italian Multicenter Study: the Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med 1993;153:1451-8. http://dx.doi.org/10.1001/archinte.1993.0041012003500
49. Puro V, Cicalini S, De Carli G, Soldani F, Antunes F, Balslev U, et al. Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. Eur J Epidemiol 2004;19:577-84. http://dx.doi.org/10.1023/B:EJEP.0000032349.57057.8a
50. Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013;34:875-92. http://dx.doi.org/10.1086/672271.
51. Puro V, De Carli G, Cicalini S, Soldani F, Balslev U, Begovac J, et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill 2005;10:260-4.
52. Werner BG, Grady GF. Accidental hepatitis-B-surface-an-tigen-positive inoculations: use of e antigen to estimate infectivity. Ann Intern Med 1982;97:367-9. http://dx.doi.org/10.7326/0003-4819-97-3-367.
53. De Carli G, Puro V, Ippolito G; Studio Italiano Rischio Occupazionale da HIV Group. Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers. Infection 2003;31 Suppl 2:22-7.
54. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-7. http://dx.doi.org/10.1056/NEJMoa011232.
55. Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 2006;130:632-8. http://dx.doi.org/10.1053/j.gastro.2006.01.034.
56. Deuffic-Burban S, Abiteboul D, Lot F, Branger M, Bouvet E, Yazdanpanah Y. Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection. Gut 2009;58:105-10. http://dx.doi.org/10.1136/gut.2007.145516.
57. Wald J. The psychological consequences of occupational blood and body fluid exposure injuries. Disabil Rehabil 2009;31:1963-9. http://dx.doi.org/10.1080/09638280902874147.